|
But 30 years after the commercials debuted, neuroscientist Read
Montague was still thinking about them. Something didn't make sense. If
people preferred the taste of Pepsi, the drink should have
dominated the market. It didn't. So in the summer of 2003, Montague
gave himself a 'Pepsi Challenge' of a different sort: to figure out why
people would buy a product they didn't particularly like.
What he found was the first data from an entirely new field:
neuromarketing, the study of the brain's responses to ads, brands, and
the rest of the messages littering the cultural landscape. Montague had
his subjects take the Pepsi Challenge while he watched their neural
activity with a functional MRI machine, which tracks blood flow to
different regions of the brain. Without knowing what they were
drinking, about half of them said they preferred Pepsi. But once
Montague told them which samples were Coke, three-fourths said that
drink tasted better, and their brain activity changed too. Coke "lit
up" the medial prefrontal cortex -- a part of the brain that controls
higher thinking. Montague's hunch was that the brain was recalling
images and ideas from commercials, and the brand was overriding the
actual quality of the product. For years, in the face of failed brands
and laughably bad ad campaigns, marketers had argued that they could
influence consumers' choices. Now, there appeared to be solid
neurological proof. Montague published his findings in the October 2004
issue of Neuron, and a cottage industry was born.
Neuromarketing, in one form or another, is now one of the hottest
new tools of its trade. At the most basic levels, companies are
starting to sift through the piles of psychological literature that
have been steadily growing since the 1990s' boom in brain-imaging
technology. Surprisingly few businesses have kept tabs on the studies -
until now. "Most marketers don't take a single class in psychology. A
lot of the current communications projects we see are based on research
from the '70s," says Justine Meaux, a scientist at Atlanta's
BrightHouse Neurostrategies Group, one of the first and largest
neurosciences consulting firms. "Especially in these early years, it's
about teaching people the basics. What we end up doing is educating
people about some false assumptions about how the brain works."
Getting an update on research is one thing; for decades, marketers
have relied on behavioral studies for guidance. But some companies are
taking the practice several steps further, commissioning their own fMRI
studies à la Montague's test. In a study of men's reactions to cars,
Daimler-Chrysler has found that sportier models activate the brain's
reward centers -- the same areas that light up in response to alcohol
and drugs -- as well as activating the area in the brain that
recognizes faces, which may explain people's tendency to
anthropomorphize their cars. Steven Quartz, a scientist at Stanford
University, is currently conducting similar research on movie trailers.
And in the age of poll-taking and smear campaigns, political
advertising is also getting in on the game. Researchers at the
University of California, Los Angeles have found that Republicans and
Democrats react differently to campaign ads showing images of the Sept.
11th terrorist attacks. Those ads cause the part of the brain
associated with fear to light up more vividly in Democrats than in
Republicans.
That last piece of research is particularly worrisome to
anti-marketing activists, some of whom are already mobilizing against
the nascent field of neuromarketing. Gary Ruskin of Commercial Alert, a
non-profit that argues for strict regulations on advertising, says that
"a year ago almost nobody had heard of neuromarketing except for Forbes readers." Now, he says, it's everywhere, and over the past year he has waged a campaign against the practice, lobbying Congress
and the American Psychological Association (APA) and threatening
lawsuits against BrightHouse and other practitioners. Even though he
admits the research is still "in the very preliminary stages," he says
it could eventually lead to complete corporate manipulation of
consumers -- or citizens, with governments using brain scans to create
more effective propaganda.
Ruskin might be consoled by the fact that many neuromarketers still
don't know how to apply their findings. Increased activity in the brain
doesn't necessarily mean increased preference for a product. And, says
Meaux, no amount of neuromarketing research can transform otherwise
rational people into consumption-driven zombies. "Of course we're all
influenced by the messages around us," she says. "That doesn't take
away free choice." As for Ruskin, she says tersely, "there is no
grounds for what he is accusing." So far, the regulatory boards agree
with her: the government has decided not to investigate BrightHouse and
the APA's most recent ethics statement said nothing about
neuromarketing. Says Ruskin: "It was a total defeat for us."
With Commercial Alert's campaign
thwarted for now, BrightHouse is moving forward. In January, the
company plans to start publishing a neuroscience newsletter aimed at
businesses. And although it "doesn't conduct fMRI studies except in the
rarest of cases," it is getting ready to publish the results of a
particularly tantalizing set of tests. While neuroscientist Montague's
'Pepsi Challenge' suggests that branding appears to make a difference
in consumer preference, BrightHouse's research promises to show exactly
how much emotional impact that branding can have. Marketers have long
known that some brands have a seemingly magic appeal; they can elicit
strong devotion, with buyers saying they identify with the brand as an
extension of their personalities. The BrightHouse research is expected
to show exactly which products those are. "This is really just the
first step," says Meaux, who points out that no one has discovered a
"buy button" in the brain. But with more and more companies peering
into the minds of their consumers, could that be far off?
| |